Search

everythinglearnresearchcommunity

for

Search:↓

Certain bacteria and fungi are linked to healthy scalps and dandruff, suggesting that the scalp's microbial balance affects its health.

Certain fats in the skin help control inflammation and health, and changing these fats through diet or supplements might treat skin inflammation.

The document concludes that better understanding the wound microbiome can improve chronic wound care by preserving helpful bacteria and targeting harmful ones.

The microbiome may be linked to hair loss and could be a target for new treatments.

Changes in skin bacteria can affect hair loss and new treatments targeting these bacteria may prevent balding without sexual side effects.

Regulatory T cells help heal skin wounds by reducing inflammation and promoting tissue repair.

Dietary interventions improved hair density and reduced dandruff by balancing scalp microbiota and reducing inflammation.

SLFC can improve scalp health and reduce sensitive scalp symptoms.

The skin's bacteria might influence the development of a hair loss condition called alopecia areata.

The document concludes that changing the scalp's microbiome might be a new way to treat hair loss.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Skin reactions to antidepressants are common but usually not serious and can be treated.

Ketoconazole cured about 70% of cutaneous leishmaniasis cases caused by Leishmania major.

Skin problems like itching, dry skin, and hair loss are more common in hepatitis C patients after interferon treatment, but lichen planus is not linked to the infection.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Gamma delta T cells in the skin help with healing and defense but can also cause autoimmune issues, and more research is needed to understand how they are activated.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Hairless HRS/J mice resist Bacillus anthracis skin infections due to high numbers of immune cells, not because they lack hair follicles.

Gene therapy shows promise for improving wound healing, but more research is needed for human use.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

3D virtual planning can help in precise skull reconstruction for advanced skin cancer, but patient-specific factors must be considered.

Over half of the diabetes patients had skin issues, with fungal infections being most common.

The human microbiome is vital for health and can help treat diseases.

An imbalanced scalp microbiome may worsen alopecia areata severity and inflammation, but treatment can partially restore balance.

Hair loss patients have different microbes in hair follicles, possibly affecting hair loss.

Early recognition of skin issues in immunocompromised patients is crucial for better outcomes.